Lysine

carboxypeptidase B1 ; Homo sapiens







43 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33624836 Productivity improvement and charge variant modulation for intensified cell culture processes by adding a carboxypeptidase B (CpB) treatment step. 2021 Sep 2
2 32515589 An 18O-Labeling Assisted LC-MS Method for Accurate Quantitation of Unprocessed C-Terminal Lysine in Therapeutic Monoclonal Antibodies. 2020 Jul 1 2
3 27038651 SpeB proteolysis with imaged capillary isoelectric focusing for the characterization of domain-specific charge heterogeneities of reference and biosimilar Rituximab. 2016 May 1 1
4 27604544 Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa). 2016 Sep 8 1
5 24297471 Unblocking the sink: improved CID-based analysis of phosphorylated peptides by enzymatic removal of the basic C-terminal residue. 2014 Feb 2
6 24478033 Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a). 2014 Apr 1
7 24488729 Improved chemical synthesis of hydrophobic Aβ peptides using addition of C-terminal lysines later removed by carboxypeptidase B. 2014 Mar 4
8 22974122 Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator. 2012 Nov 5
9 19010784 Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. 2009 Jan 9 1
10 17189688 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). 2007 Mar 1 1
11 17296336 Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function. 2007 Jun 1 1
12 17167091 Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells. 2006 Dec 13 1
13 14715654 Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin. 2004 Apr 2 1
14 14580393 Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells. 2003 Dec 1
15 11027681 Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. 2001 Jan 5 3
16 11442827 alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. 2001 Jun 1
17 10974350 Plasminogen and tissue plasminogen activator interact with antithrombin III. 2000 Sep 15 1
18 11012092 Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. 2000 1
19 11215380 [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)]. 2000 Nov 1
20 10021925 Catalytic activity of carboxypeptidase B and of carboxypeptidase Y with anisylazoformyl substrates. 1999 Jan 18 1
21 10052689 Characterization of isoforms of human mitochondrial creatine kinase by isoelectric focusing. 1999 Jan 22 2
22 9102401 Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. 1997 Feb 28 1
23 9153272 Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. 1997 May 15 1
24 7727441 Activation and characterization of procarboxypeptidase B from human plasma. 1995 May 2 1
25 8530448 Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyl-terminal lysine and cAMP-dependent signal transduction. 1995 Dec 22 2
26 8112348 Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen. 1994 Feb 1 3
27 8428004 The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. 1993 Feb 15 1
28 1627572 Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. 1992 Jul 14 2
29 1776140 The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation. 1991 Oct 1 2
30 1939157 Carboxyl-terminal proteolytic processing of matrix Gla protein. 1991 Nov 5 1
31 1939207 Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. 1991 Nov 15 2
32 2068071 A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. 1991 Jul 15 1
33 2110898 Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s. 1990 Apr 30 1
34 2466697 Limited proteolysis of tumor cells increases their plasmin-binding ability. 1989 Mar 13 1
35 2526127 Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin. 1989 Jul 25 1
36 2458720 Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin. 1988 Sep 15 2
37 2963831 Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. 1988 Mar 1
38 3156054 C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen. 1985 Mar 11 1
39 6437858 Molecular mechanism for the production of multiple forms of MM creatine kinase. 1984 Nov 15 1
40 6404277 Enkephalin convertase: potent, selective, and irreversible inhibitors. 1983 Mar 29 1
41 7287747 The molecular basis of the heterogeneity of the gamma subunit of 7 S nerve growth factor. 1981 Nov 10 1
42 667683 Effect of the basic amino-acid side chain length and the penultimate residue on the hydrolysis of benzoldipeptides by carboxypeptidase B. 1978 May 1
43 974098 Studies on the nature of different molecular forms of glucose-6-phosphate dehydrogenase purified from human leukocytes. 1976 Oct 11 1